| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.60B | 27.47B | 23.91B | 14.70B | 20.07B | 21.08B |
| Gross Profit | 8.01B | 7.86B | 5.35B | 3.19B | 4.40B | 3.91B |
| EBITDA | 5.29B | 4.88B | 3.43B | 2.06B | 2.76B | 2.55B |
| Net Income | 3.29B | 3.02B | 2.10B | 1.17B | 1.64B | 1.46B |
Balance Sheet | ||||||
| Total Assets | 45.74B | 44.31B | 38.10B | 35.87B | 32.22B | 37.25B |
| Cash, Cash Equivalents and Short-Term Investments | 2.50B | 3.51B | 1.74B | 2.36B | 4.25B | 1.64B |
| Total Debt | 13.51B | 7.89B | 7.38B | 8.12B | 5.12B | 11.46B |
| Total Liabilities | 18.49B | 16.63B | 12.65B | 12.37B | 9.51B | 15.82B |
| Stockholders Equity | 27.00B | 27.44B | 25.24B | 23.32B | 22.56B | 21.39B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.44B | -2.17B | -6.12B | 5.36B | 1.52B |
| Operating Cash Flow | 0.00 | 2.80B | -2.02B | -6.08B | 5.43B | 2.74B |
| Investing Cash Flow | 0.00 | -833.58M | 593.61M | 1.40B | 4.46B | -694.51M |
| Financing Cash Flow | 0.00 | -184.03M | 801.30M | 2.79B | -6.98B | -2.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥16.20B | 8.96 | ― | 4.00% | 19.97% | 69.40% | |
77 Outperform | ¥20.04B | 7.77 | ― | 2.65% | 32.24% | 117.46% | |
74 Outperform | ¥22.83B | 6.79 | ― | 2.76% | 45.01% | 89.71% | |
67 Neutral | ¥15.91B | 6.50 | ― | 1.47% | 20.82% | 9.86% | |
66 Neutral | ¥21.08B | 12.18 | ― | ― | 57.57% | 57.09% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
61 Neutral | ¥19.53B | 9.24 | ― | 4.52% | -3.46% | -42.76% |